📰 Eceptor News
Page 168 - Eceptor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eceptor. Real-time updates on events, politics, business and more.
January 11, 2022
The current study examines the role of heterologous vaccination, an area that lacks much clarity.
January 10, 2022
Researchers developed a human A549 lung epithelial cell-based model to probe SARS-CoV-2 replication.
January 10, 2022
Researchers demonstrate the role of integrins in the establishment of the SARS-CoV-2 infection.
January 10, 2022
Researchers investigate the relationship between the SARS-CoV-2 Omicron variant and immune system based on self/nonself short constituent sequences.
January 10, 2022
A new study investigated SARS-CoV-2 cell-to-cell transmission in the context of cell-free infection and compared it to SARS-CoV.
January 10, 2022
In a new study, researchers used a cell-cell fusion assay to extract potentially cleaved spike protein products from syncytia in order to explore the functional and biochemical characteristics of spike (S) protein when it engages its receptor ACE2 in living cells.
January 10, 2022
A recent study uses an artificial intelligence model to investigate Omicron's mutations and its infectivity, vaccine escape capability, and susceptibility to monoclonal antibodies.
January 10, 2022
Press Release 4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology Collaboration
January 10, 2022
Today saw the launch of a dedicated grant program aimed at advancing therapeutic discovery for follicular lymphoma (FL), The Follicular Lymphoma Foundation (FLF) CURE FL Awards - Curative Research to Eliminate Follicular Lymphoma.
January 9, 2022
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries.